Judit Morelló

1.5k total citations
55 papers, 1.1k citations indexed

About

Judit Morelló is a scholar working on Infectious Diseases, Hepatology and Virology. According to data from OpenAlex, Judit Morelló has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 17 papers in Hepatology and 13 papers in Virology. Recurrent topics in Judit Morelló's work include HIV/AIDS drug development and treatment (22 papers), Hepatitis C virus research (17 papers) and HIV Research and Treatment (13 papers). Judit Morelló is often cited by papers focused on HIV/AIDS drug development and treatment (22 papers), Hepatitis C virus research (17 papers) and HIV Research and Treatment (13 papers). Judit Morelló collaborates with scholars based in Portugal, Spain and United States. Judit Morelló's co-authors include Vincent Soriano, Sonia Rodríguez‐Nóvoa, Gema González‐Pardo, Eugenia Vispo, Pablo Barreiro, Emília C. Monteiro, Sofia A. Pereira, Pablo Labarga, Lorena Cuenca‐Bermejo and Carmen de Mendoza and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Judit Morelló

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judit Morelló Portugal	20	561	331	285	274	181	55	1.1k
Inge Dierynck United States	17	696 1.2×	374 1.1×	438 1.5×	397 1.4×	116 0.6×	35	1.2k
K. Tsuchiya Japan	23	805 1.4×	229 0.7×	523 1.8×	55 0.2×	150 0.8×	76	1.6k
Marie‐Claude Gagnieu France	19	278 0.5×	273 0.8×	71 0.2×	239 0.9×	35 0.2×	63	889
T Delahunty United States	15	391 0.7×	344 1.0×	155 0.5×	83 0.3×	92 0.5×	26	1.6k
Gerond Lake‐Bakaar United States	17	227 0.4×	454 1.4×	57 0.2×	292 1.1×	41 0.2×	52	1.1k
Neil Buss Switzerland	13	375 0.7×	130 0.4×	252 0.9×	48 0.2×	71 0.4×	17	655
Gabriela Bleiber Switzerland	19	841 1.5×	244 0.7×	830 2.9×	53 0.2×	163 0.9×	24	1.5k
Chan‐Loi Yong United States	13	260 0.5×	400 1.2×	101 0.4×	432 1.6×	13 0.1×	22	944
Elsa Mondou United States	19	382 0.7×	1.2k 3.6×	189 0.7×	1.0k 3.8×	44 0.2×	53	1.7k
Mustafa A. Noor United States	14	900 1.6×	208 0.6×	749 2.6×	46 0.2×	1.1k 6.1×	20	1.6k

Countries citing papers authored by Judit Morelló

Since Specialization

Citations

This map shows the geographic impact of Judit Morelló's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Morelló with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Morelló more than expected).

Fields of papers citing papers by Judit Morelló

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Morelló. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Morelló. The network helps show where Judit Morelló may publish in the future.

Co-authorship network of co-authors of Judit Morelló

This figure shows the co-authorship network connecting the top 25 collaborators of Judit Morelló. A scholar is included among the top collaborators of Judit Morelló based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judit Morelló. Judit Morelló is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fonseca, Nuno Moreira, Ana Faria, Emília C. Monteiro, et al.. (2023). Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity. Genes. 14(9). 1719–1719. 9 indexed citations

Branco, Patrícia, Maria João Jervis, Daniel Pinto, et al.. (2023). Fibrosis of Peritoneal Membrane, Molecular Indicators of Aging and Frailty Unveil Vulnerable Patients in Long-Term Peritoneal Dialysis. International Journal of Molecular Sciences. 24(5). 5020–5020. 3 indexed citations

Branco, Patrícia, Maria João Jervis, Anabela Rodrigues, et al.. (2022). Alpha‐klotho and peritoneal membrane status: A hypothesis generating study. European Journal of Clinical Investigation. 53(3). e13903–e13903. 2 indexed citations

Carvalho, Maria Esther de, Judit Morelló, Fátima Nogueira, et al.. (2022). Synthetic Red Blood Cell-Specific Glycolytic Intermediate 2,3-Diphosphoglycerate (2,3-DPG) Inhibits Plasmodium falciparum Development In Vitro. Frontiers in Cellular and Infection Microbiology. 12. 840968–840968. 3 indexed citations

Pité, Helena, et al.. (2020). Metabolic Dysfunction and Asthma: Current Perspectives. SHILAP Revista de lepidopterología. 2 indexed citations

Pité, Helena, Judit Morelló, Emília C. Monteiro, et al.. (2020). <p>Metabolic Dysfunction and Asthma: Current Perspectives</p>. Journal of Asthma and Allergy. Volume 13. 237–247. 33 indexed citations

Morelló, Judit, et al.. (2017). Implications of sulfotransferase activity in interindividual variability in drug response: clinical perspective on current knowledge. Drug Metabolism Reviews. 49(3). 357–371. 17 indexed citations

Morelló, Judit, et al.. (2014). Monitoring of the lactonase activity of paraoxonase‐1 enzyme in HIV‐1‐infection. Journal of the International AIDS Society. 17(4S3). 19682–19682. 4 indexed citations

Morelló, Judit, Elena Álvarez, Lorena Cuenca‐Bermejo, et al.. (2011). Short Communication: Use of Serum Bilirubin Levels as Surrogate Marker of Early Virological Response to Atazanavir-Based Antiretroviral Therapy. AIDS Research and Human Retroviruses. 27(10). 1043–1045. 10 indexed citations

10.

Rallón, Norma, Judit Morelló, Pablo Labarga, et al.. (2011). Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C. Clinical Infectious Diseases. 53(12). 1291–1295. 10 indexed citations

11.

Garrido, Carmen, Carmen de Mendoza, Elena Álvarez, et al.. (2011). Plasma Raltegravir Exposure Influences the Antiviral Activity and Selection of Resistance Mutations. AIDS Research and Human Retroviruses. 28(2). 156–164. 20 indexed citations

12.

Jiménez‐Nácher, Inmaculada, et al.. (2011). Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients. Expert Opinion on Drug Metabolism & Toxicology. 7(4). 457–477. 31 indexed citations

13.

Vispo, Eugenia, Pablo Labarga, Josep M. Guardiola, et al.. (2010). Preemptive Erythropoietin Plus High Ribavirin Doses to Increase Rapid Virological Responses in HIV Patients Treated for Chronic Hepatitis C. AIDS Research and Human Retroviruses. 26(4). 419–424. 5 indexed citations

14.

Morelló, Judit, Lorena Cuenca‐Bermejo, Vincent Soriano, et al.. (2010). Influence of a Single Nucleotide Polymorphism at the Main Ribavirin Transporter Gene on the Rapid Virological Response to Pegylated Interferon–Ribavirin Therapy in Patients with Chronic Hepatitis C Virus Infection. The Journal of Infectious Diseases. 202(8). 1185–1191. 30 indexed citations

15.

Briz, Verónica, Carmen Garrido, Eva Poveda, et al.. (2009). Raltegravir and Etravirine Are Active against HIV Type 1 Group O. AIDS Research and Human Retroviruses. 25(2). 225–227. 31 indexed citations

16.

Rodríguez‐Nóvoa, Sonia, Pablo Labarga, Vincent Soriano, et al.. (2009). Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study. Clinical Infectious Diseases. 48(11). e108–e116. 194 indexed citations

17.

Rodríguez‐Nóvoa, Sonia, Judit Morelló, Pablo Barreiro, et al.. (2008). Switch from Ritonavir-Boosted to Unboosted Atazanavir Guided by Therapeutic Drug Monitoring. AIDS Research and Human Retroviruses. 24(6). 821–825. 31 indexed citations

18.

Morelló, Judit, Sonia Rodríguez‐Nóvoa, Carmen de Mendoza, et al.. (2008). Short Communication: Association between Tipranavir Plasma Levels and Virological Response in HIV-Infected Patients. AIDS Research and Human Retroviruses. 24(3). 389–391. 2 indexed citations

19.

Soriano, Vincent, Pilar García‐Gascó, Eugenia Vispo, et al.. (2007). Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial. Journal of Antimicrobial Chemotherapy. 61(1). 200–205. 66 indexed citations

20.

Mendoza, Carmen de, Judit Morelló, Pilar García‐Gascó, Sonia Rodríguez‐Nóvoa, & Vincent Soriano. (2007). Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients. Expert Opinion on Pharmacotherapy. 8(6). 839–850. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact